OIG Files: Vignettes of the Week

OIG Files: Vignettes of the Week

If you missed Eric opining on LinkedIn this week, here are some quick pieces of information including: an infectious disease doctor, a case in NJ, and a Bill that was signed into law. Another great case from my former OIG coworkers in NJ. This one should concern...
OIG Files: Go Your Own Way 

OIG Files: Go Your Own Way 

While CMS reported that is collected half of the overpayments previously identified by OIG, the OIG in another recent review (full report) found that number to substantially less. The OIG is the watchdog for HHS.  All OIGs serve in this role for the respective...
Don’t Ride the Carousel

Don’t Ride the Carousel

In some of my recent posts, I have mentioned the term “carouselling,” as it pertains to the recycling of diabetic testing supplies.  I have had several people inquire about this term and how the scheme works. Carouselling Is the purchasing and reselling of...
Investigative Competence

Investigative Competence

I spent about 25 years in federal law enforcement, and most of that time was as a Senior Special Agent at HHS-OIG.  I loved working there, and I loved doing healthcare fraud investigations.  When I was exploring retirement, and what I was interested in doing...

OIG Files: The Elizabeth Holmes (Theranos) Verdict

For those of you who have been keeping up with the Elizabeth Holmes/Theranos trial, you likely have seen that there was a very mixed verdict. Holmes was convicted on some counts, acquitted on some and the jury was deadlocked on others. From a reader’s perspective, it...
OIG Files: A Disastrous Investigative Misstep

OIG Files: A Disastrous Investigative Misstep

Recently, Advize Health was involved in a matter pertaining to some medical record audits and investigations that were ongoing with a Social Adult Day Care (SADC), located on the West Coast.  For a five year period, this SADC was the subject of audits,...

OIG Files: The Mixing Bowl of Medication

In 2012, the National Council on Prescription Drug Programs (NCPDP) made a change to the manner in which a compounded medication should be submitted to a Pharmacy Benefit Manager (PBM) for reimbursement.  Previously, the requirement was to only list the most expensive...